Two new BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, reveal scientists. The findings of the study were published in iClinical Cancer Research/i, a journal of the American Association for Cancer Research. According to Dr. Sosman, professor of medicine at Vanderbilt-Ingram Cancer Center in Nashville, Tenn., "About ...Tuesday, 31 December 2013
New Molecular Targets Identified in Some Hard-to-treat Melanomas Provide Potential Treatment Option, Say Researchers
Two new BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, reveal scientists. The findings of the study were published in iClinical Cancer Research/i, a journal of the American Association for Cancer Research. According to Dr. Sosman, professor of medicine at Vanderbilt-Ingram Cancer Center in Nashville, Tenn., "About ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment